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Sirt3 is a mitochondrial sirtuin, predominantly expressed in highly metabolic tissues. Germline ablation of
Sirt3 has major metabolic consequences, including increased susceptibility to metabolic damage and
oxidative stress after high fat feeding. In order to determine the contribution of liver and skeletal muscle to
these phenotypes, we generated muscle-specific Sirt3 (Sirt3skm2/2) and liver-specific Sirt3 (Sirt3hep2/2)
knock-out mice. Despite a marked global hyperacetylation of mitochondrial proteins, Sirt3skm2/2 and
Sirt3hep2/2 mice did not manifest any overt metabolic phenotype under either chow or high fat diet
conditions. Similarly, there was no evidence for increased oxidative stress in muscle or liver when Sirt3 was
ablated in a tissue-specific manner. These observations suggest that the mitochondrial hyperacetylation
induced by Sirt3-deletion in a tissue specific manner is not necessarily linked to mitochondrial dysfunction
and does not recapitulate the metabolic abnormalities observed in the germline Sirt3 knock-out mice.
S
irt3 is one of the 7members of the sirtuin family of NAD1-dependent deacetylases. Together with Sirt4 and
Sirt5, Sirt3 localizes predominantly in the mitochondria1. Importantly, Sirt3 is a primary regulator of
mitochondrial protein acetylation. The absence of Sirt3 enhances global acetylation of mitochondrial
proteins, while no significant changes in protein acetylationwere observed in Sirt42/2 and Sirt52/2mitochondria2.
Sirt3 expression is highly enriched in metabolic tissues like liver, brown adipose tissue (BAT), heart, skeletal
muscle and kidney3. Sirt3 expression increases in muscle after exercise training, fasting and caloric restriction
(CR), while it decreases upon long-term high fat feeding4,5. In liver and BAT Sirt3 expression also increases after
CR and fasting, as well as upon cold exposure in BAT3,6.
Germline Sirt32/2 mice display increased levels of cellular reactive oxygen species (ROS)7–12 and impaired
cellular respiration after prolonged fasting6 in different tissues, including the muscle, liver, brain or the inner ear.
In contrast, Sirt3 overexpression in vitro enhancesmitochondrial respiration13 and reduces ROS production3. Not
surprisingly, whole body Sirt3 knock-out mice are sensitized to high fat diet (HFD)-induced obesity, insulin
resistance, hyperlipidemia and steatohepatitis14. The etiology of such defects might be found in the ability of Sirt3
to enhance fat oxidation and improve anti-oxidant defences6,9,10,14–16. However, while recent reports show that
Sirt3 suppresses oxidative stress under CR9,10,12, it still remains to be elucidated whether Sirt3 might influence
HFD-induced oxidative stress.
All studies to date used germline Sirt3 deficient mice to study the role of Sirt3 on metabolism, making it
impossible to distinguish the contribution of individual tissues to the phenotypic changes. Liver and muscle are
two of the most important tissues determining whole body metabolism: skeletal muscle is the largest organ in
mammals, contributing to 640% of the body mass, and it plays a major role in whole body metabolism, as it is
vital for insulin-mediated glucose disposal and lipid catabolism. In turn, the liver is central to regulate glucose,
lipid and cholesterol homeostasis. Altered function of these tissues is, thus, likely to contribute to the systemic
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metabolic disturbances observed in the germline Sirt3 knock-out
mice. Here, we report the generation of the first set of tissue-specific
Sirt3 knockout mouse models in muscle and liver, and describe how
Sirt3 deletion in these tissues, despite leading to mitochondrial pro-
tein hyperacetylation, hasminor phenotypic consequences. This sug-
gests that themetabolic abnormalities observed in the germline Sirt3-
KO mice may not stem from the liver or muscle deficiencies.
Results
Generation of the Sirt3skm2/2 and Sirt3hep2/2 mice. To investigate
the role of Sirt3 in muscle and liver, as well as its impact on whole
body metabolism, we generated a mouse line in which exons 2 and 3
were flanked with LoxP sites, priming it for subsequent deletion
using the Cre-LoxP system (Fig. 1A). Sirt3L2/L2 mice, bearing floxed
Sirt3 L2 alleles, were bred with mice expressing the Cre recombinase
under the control of the human a-skeletal actin promoter17, yielding
HSA-CreTg/0/Sirt3L2/L2 mutants (Sirt3skm2/2), in which Sirt3 is
selectively ablated in the skeletal muscles. A distinct mouse line, in
which Cre expression was under the control of the albumin
promoter18, was used to generate Alb-CreTg/0/Sirt3L2/L2 mice
(Sirt3hep2/2), in which Sirt3 is selectively ablated in the liver.
Sirt3skm2/2 and Sirt3hep2/2 mice were born at a normal Mendelian
ratio and had a normal appearance. Only residual Sirt3 mRNA levels
were detected in skeletal muscle (gastrocnemius, soleus and EDL) of 8-
week-old Sirt3skm2/2 mice (Fig. 1B), demonstrating that Sirt3 was
efficiently ablated in Sirt3skm2/2 muscles. In addition to the skeletal
muscle, a 35% reduction in Sirt3 mRNA levels was observed in the
heart of Sirt3skm2/2 mice, whereas no significant reduction was seen in
other tissues (Fig. 1B). Sirt3 mRNA levels were also blunted in livers
from Sirt3hep2/2 mice of 8 weeks of age, but normal in other tissues
(Fig. 1C). In line with the above results, the Sirt3 protein was unde-
tectable in the skeletal muscle of Sirt3skm2/2 mice, but remained un-
affected in the liver (Fig. 1D); conversely the Sirt3 protein was only
absent in the liver in the Sirt3hep2/2 mice (Fig. 1E), confirming that the
Sirt3 deletion is efficient and restricted to the targeted tissue.
The absence of Sirt3 had no impact on the expression of a vast set
of metabolic genes in either muscle (Fig. 1F) or liver (Fig. 1G). Of
note, we did not detect any compensatory increase in the expression
of the other mitochondrial sirtuins (Sirt4 and Sirt5) in the two Sirt3-
deficient tissues.We also determined Pgc1a and Scd1 expression, two
genes whose levels were reported to be altered in germline Sirt3-KO
tissues5,14; however, we could not detect any significant change in
their expression in our mutant mice. These results suggest that
Figure 1 | Generation, validation and expression of metabolic genes for the Sirt3hep2/2 and Sirt3skm2/2mice. (A) Targeting strategy used to generate the
tissue-specific Sirt3-deficient mice. Maps of the Sirt3 genomic locus showing the conditional allele (upper panel) and the KO allele (lower panel). The
white arrowheads indicate the LoxP sites and the black vertical bars represent the respective exons. (B–C) Sirt3mRNA expression levels in different tissues
of Sirt3skm1/1 and Sirt3skm2/2 mice (B) and of Sirt3hep1/1 and Sirt3hep2/2 mice (C); n54 per group. (D–E) Sirt3 protein expression as assessed by western
blotting in muscle (D) and liver (E) of the Sirt3-deficient mouse models. Porin is used as a loading control. (F–G) Gene expression in gastrocnemius
muscle of Sirt3skm1/1 and Sirt3skm2/2 mice (F) and in liver of Sirt3hep1/1 and Sirt3hep2/2 mice (G) after 18 weeks of HFD. mRNA levels were normalized to
36B4. Data represent the mean 6 SEM for at least four animals per group.
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muscle or liver-specific deletion of Sirt3 does not have amajor impact
on the expression of genes involved in metabolic control. We only
performed this gene expression analysis in mice subjected to HFD,
since young, unchallenged mice show no phenotype whatsoever,
both in our hands and in previous reports2.
Normal metabolic phenotype in Sirt3hep2/2mice fed chow or high
fat diet. We next subjected Sirt3hep1/1 and Sirt3hep2/2 mice to a
standardized phenotyping protocol before and after high fat diet
(HFD) feeding (Fig. 2A). Body weight and body composition were
similar in both genotypes before and after HFD (Fig. 2B and 2C).
The weight gain curves of the Sirt3hep2/2 mice were indistinguishable
from those of the Sirt3hep1/1 mice (data not shown). During indirect
calorimetry using the comprehensive lab animal monitoring system
(CLAMS), no difference was observed in food intake (Fig. 2D), mean
VO2 (Fig. 2E), mean respiratory exchange ratio (RER) (Fig. 2F) or
spontaneous locomotor activity (Fig. 2G), before and after HFD. At
sacrifice, the weight of the liver, epididymal white fat or interscapular
brown fat depots were not different between the genotypes (Fig. 2H). To
specifically test the contribution of Sirt3 deletion in the liver to glucose
homeostasis we performed an intraperitoneal glucose tolerance test
(ipGTT) and an insulin tolerance test (ipITT) both before (data not
shown) and after HFD. Again no significant differences between
Sirt3hep1/1 and Sirt3hep2/2 animals were detected in these experiments
(Fig. 2I, 2J and data not shown). All these data contrast with the results
obtained in germline Sirt3-deficient mice, where Sirt3-deficiency was
shown to sensitize the liver to HFD-induced damage14.
Germline Sirt3-KOmice have also been reported to display altered
aminoacid profiles in blood and liver15. We therefore also analyzed
the blood aminoacid profiles, but could not detect differences
between the Sirt3hep2/2 and Sirt3hep1/1 samples, both in the fed state
(data not shown) and after a 24 h fast (Fig. 2K).
Sirt3 has also been suggested to act as a key modulator of ketone
body production, a glucose-sparing energy substrate in the fasting
state mostly synthesized by hepatocytes19. However, blood levels of
b-hydroxybutyrate, a surrogate marker of the activity of this path-
way, were similar in Sirt3hep1/1 and Sirt3hep2/2 mice both before and
after a 24 h fast at 8-weeks of age (Fig. 2L). This contrasts with the
germline Sirt3 knock-out mice, which displayed a maximal decrease
in b-hydroxybutyrate after a 24 h fast19.
Finally, since germline Sirt3-KO mice display abnormal fatty
acid metabolism and aberrant blood acylcarnitine profiles14,15, we
analyzed the blood acylcarnitines in Sirt3hep1/1 and Sirt3hep2/2
animals in both fed (data not shown) and fasted (24 h fast) states
Figure 2 | Metabolic phenotyping of Sirt3hep2/2mice. (A) Experimental schedule of the clinical phenotyping protocol. MCB: non-invasive monitoring
of body fat and leanmass by EchoMRI, energy expenditure by indirect calorimetry (CLAMS system), and blood sampling for metabolite analysis; I: intra-
peritoneal glucose tolerance test (ipGTT); T: intra-peritoneal insulin tolerance test (ipITT); {: sacrifice and collection of blood and organs for further
analysis. (B) Body weight and (C) body composition of Sirt3hep1/1 and Sirt3hep2/2 mice before and after 8 weeks of HFD. (D–G) Daily food intake (D),
mean O2 consumption (VO2; E), mean respiratory exchange ratio (RER; F) and total ambulatory locomotor activity (G) as measured over a 24 h period
before and after HFD. (H) Relative weight of tissues normalized by body weight in Sirt3hep1/1 and Sirt3hep2/2mice. (I–J) Intra-peritoneal glucose tolerance
test (ipGTT; I), and intra-peritoneal insulin tolerance test (ipITT; J) in mice fed a HFD for 15-17 weeks. The bar graphs represent the average area under
the curve (AUC). (K) Levels of the indicated aminoacids were determined in plasma from 8weeks oldmalemice. (L) b-hydroxy-butyrate was analysed in
plasma from 8 weeks old male mice before and after a 24h fasting period. (M) Acylcarnitine levels in plasma from 8 weeks old male mice. Results are
represented as mean values (n58210 mice for each group) 6 standard error of the mean (SEM).
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(Fig. 2M), but again could not detect any significant difference in
the acylcarnitine levels between the two genotypes.
All these findings combined suggest that the altered metabolic
response of germline Sirt3-KO mice subjected to HFD14 or to fast-
ing15,19 are not due to the absence of Sirt3 in hepatocytes, but rather
stem from the indirect effect of Sirt3 ablation in some other tissue.
No metabolic phenotype in Sirt3skm2/2 mice under chow or high
fat diet. We next determined whether the phenotype observed in
the germline Sirt3 knock-out mice could be due to another major
metabolic tissue, i.e. the skeletal muscle. We therefore subjected
Sirt3skm2/2 and Sirt3skm1/1 mice to a similar phenotyping protocol
than the one described for the liver-specific Sirt3-deficient mice
(Fig. 3A). No differences in body weight (Fig. 3B) and body
composition (Fig. 3C) were observed between Sirt3skm2/2 and
Sirt3skm1/1 mice, even under HFD conditions. Consistent with
the similarities in body weight, evaluation using CLAMS
indicated that food intake (Fig. 3D), mean VO2 (Fig. 3E), mean
RER (Fig. 3F) and spontaneous locomotor activity (Fig. 3G) were
similar between the two genotypes before and after HFD. In
addition, no significant differences were observed in the weight
of different tissues at sacrifice (Fig. 3H). Upon an intraperitoneal
glucose tolerance test (ipGTT) the glucose excursion (Fig. 3I; left
panel) and glucose-induced insulin secretion (Fig. 3I; right panel)
were comparable between the two genotypes. Also, the drop and
recovery of blood glucose levels upon an intraperitoneal insulin
tolerance test (ipITT) were, again, not distinct between the two
genotypes (Fig. 3J).
To further evaluate possible phenotypic differences between the
Sirt3skm2/2 and Sirt3skm1/1 mice, we exposed the mice to a cold chal-
lenge (4uC). Mice from both genotypes similarly maintained their
core body temperature for at least 6 hours after a 24 h fast (Fig. 3K),
or after 14 weeks of HFD (Supl. Fig. 1A), indicating that muscle Sirt3
is not essential for cold-induced adaptive thermogenesis. Exercise
increases Sirt3 expression in muscle4,5, suggesting a role for Sirt3 in
exercise physiology. Sirt3skm2/2 and Sirt3skm1/1 mice, however, ran a
similar distance until exhaustion both before and afterHFD (Fig. 3L).
Also no difference in endurance running was present before and after
a 24 h fast (Supp. Fig. 1B). In addition, both the heart rate (Fig. 3M)
and systolic blood pressure (Fig. 3N)were similar between Sirt3skm2/2
and Sirt3skm1/1 mice, indicating that the partial reduction in Sirt3
mRNA levels found in the Sirt3skm2/2 hearts has no major impact on
cardiac function.
Altogether, these data indicate that Sirt3skm2/2 mice are metaboli-
cally indistinguishable from controlmice under both chow andHFD.
Thus, the absence of Sirt3 in the skeletal muscle by itself cannot
Figure 3 | Metabolic phenotyping of Sirt3skm2/2mice. (A) Experimental schedule of the clinical phenotyping protocol. For abbreviations see legend of
Fig. 2A; E: endurance exercise on a treadmill; N: non-invasive blood pressure measurement (NIBP); C: cold test. (B) Body weight and (C) body
composition of Sirt3skm1/1 and Sirt3skm2/2 mice before and after 8 weeks of HFD. (D–G) Daily food intake (D), mean O2 consumption (VO2; E), mean
respiratory exchange ratio (RER; F) and total ambulatory locomotor activity (G) as measured over a 24 h period before and after HFD. (H) Relative
weight of tissues normalized by body weight in Sirt3skm1/1 and Sirt3skm2/2mice. (I) Intra-peritoneal glucose tolerance test (ipGTT, left panel) and plasma
insulin during ipGTT (right panel) inmice fed aHFD for 16weeks. (J) Intra-peritoneal insulin tolerance test (ipITT) in Sirt3skm1/1 and Sirt3skm2/2mice fed
a HFD for 17 weeks. (I and J) The bar graph (inner panels) represents the average area under the curve (AUC). (K) Sirt3skm1/1 and Sirt3skm2/2mice fasted
for 24h were exposed to 4uC for 6 h and rectal temperature wasmonitored. (L) Endurance exercise test on Sirt3skm1/1 and Sirt3skm2/2mice before and after
12 weeks of HFD. (M) Heart rate and (N) systolic blood pressure were measured in Sirt3skm1/1 and Sirt3skm2/2 mice after 10 weeks on HFD. Results are
presented as mean values (n58210 mice for each group) 6 SEM.
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explain the metabolic phenotype observed in the germline deficient
Sirt3-KO animals.
Mitochondrial protein hyperacetylation but normal oxidative
stress in Sirt3-deficient tissues. The fact that Sirt3 is a mito-
chondrial protein prompted us to investigate the integrity of the
mitochondria in both tissue-specific Sirt32/2 mouse models after
HFD treatment, a stress after which we expect the effects of Sirt3
deficiency to be accentuated. The protein levels of subunits from the
mitochondrial respiratory complexes I, II, IV and V were indis-
tinguishable in Sirt3skm2/2 and Sirt3skm1/1 muscle, and in Sirt3hep2/2
and Sirt3hep1/1 liver (Fig. 4A). In line with the observations in
germline Sirt32/2 mice2, there was a marked increase in global
mitochondrial protein acetylation in the tissues where the Sirt3
gene had been deleted (Fig. 4B and 4C). We next evaluated the
acetylation levels of specific Sirt3 targets. Sirt3 interacts with
and deacetylates Ndufa9, a subunit of complex I13. Consistently,
we observed increased acetylation of some members of the
Ndufa9-containing complex I in livers from the Sirt3hep2/2 mice or
quadriceps muscle from the Sirt3skm2/2 mice, as compared with their
respective wild type controls (Fig. 4D, top panels). However, this
increased acetylation did not lead to any change in maximal com-
plex I or complex IV activities (Fig. 4E). As an internal control, we
measured the activity of citrate synthase, a mitochondrial enzyme
from the Krebs cycle not belonging to the electron transport chain,
whose activity was also unchanged in the absence of Sirt3 in both
mouse models (Fig. 4E). To further examine mitochondrial function
in the absence of Sirt3 we measured oxygen consumption in Sirt3L2/L2
primary hepatocytes-with the Sirt3 gene flanked with LoxP sites- in
which we acutely deleted the Sirt3 gene by an adenoviral infection
with Cre. Oxygen consumption rate (OCR) was not affected by the
absence of Sirt3 (Fig. 4F and Suppl. Fig. 2A).
Sirt3 deficiency has also been correlated with low levels of cellular
ATP13. We therefore measured ATP levels in Sirt3skm1/1 and Sirt3skm2/2
gastrocnemius muscle and in Sirt3hep1/1 and Sirt3hep2/2 liver, but could
not detect differences between tissues from the different genotypes
Figure 4 | Hyperacetylation of mitochondrial proteins but normal ROS markers in Sirt3hep2/2 and Sirt3skm2/2mice subjected to HFD. (A) Protein
expression levels of complex I, II, IV and V in isolated mitochondria of Sirt3skm1/1 and Sirt3skm2/2 muscle (left panels) and Sirt3hep1/1 and Sirt3hep2/2 livers (right
panels). (B, C) Acetylation status of mitochondrial proteins extracted frommuscle and liver of Sirt3skm1/1 and Sirt3skm2/2mice (B) and Sirt3hep1/1 and Sirt3hep2/2
mice (C). Mitochondrial protein lysates were subjected to western blotting using an anti-acetylated lysine antibody (Ac-K) and porin as a loading control.
(D) Acetylation level of complex I members (top two rows of panels) and Sod2 (bottom two rows of panels) in Sirt3skm1/1 and Sirt3skm2/2muscle (left panels) or
Sirt3hep1/1 and Sirt3hep2/2 livers (right panels). Endogenous Ndufa9 or Sod2 were immunopurified frommuscle lysates and immunoblotted using Ndufa9/Sod2
and Ac-K antibodies. (E) Complex I (CI), complex IV (CIV) and Citrate synthase (CS) activities in Sirt3skm1/1 and Sirt3skm2/2 muscle (left panel) or Sirt3hep1/1
and Sirt3hep2/2 (right panel). (F) Oxygen consumption rate (OCR) from primary hepatocytes obtained from Sirt3L2/L2 mice infected with the indicated viruses.
(G) ATP levels were measured from the indicated tissue lysates. (H–K) Activities of mitochondrial Sod2 (H) and catalase (I) and levels of 4-hydroxy-2-nonenal
(HNE; J) and GSH/GSSG ratio (K) in muscle and liver lysates of Sirt3skm1/1 and Sirt3skm2/2 mice (left panels) or Sirt3hep1/1 and Sirt3hep2/2 mice (right panels).
Measurements in panels E–K were determined using samples from at least four mice per genotype. All the samples used for these studies come from mice
subjected to the HFD treatment, sacrificed in fed state. Data are represented as mean 6 SEM.
www.nature.com/scientificreports
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(Fig. 4G). Accordingly, we did not detect differences in the phosphor-
ylation status of the AMP/ATP sensing AMP-activated protein kinase
(AMPK), suggesting that Sirt3 deletion in a tissue-specific fashion does
not affect intracellular energy charge (Suppl. Fig. 2B).
Sirt3 has been shown to reduce oxidative stress, mostly through
deacetylating and activating the mitochondrial ROS scavenger
Sod29,10,12,16. We therefore also determined Sod2 acetylation status
in the absence of Sirt3; as reported, Sirt3-deficient tissues presented
increased levels of acetylated Sod2 (Fig. 4D, lower panels). In con-
trast, Sirt3 gene ablation did not affect the activity of Sod2 (Fig. 4H),
nor that of catalase, another key ROS scavenger (Fig. 4I). We next
measured a few markers of oxidative stress, such as the level of 4-
hydroxy-2-nonenal (HNE; a marker for lipid peroxidation) and glu-
tathione, in liver and muscle from our mutant mouse models after
HFD treatment. No difference in these parameters was observed
between Sirt3-deficient tissues and their respective controls
(Fig. 4J-K). These results show that tissue-specific ablation of Sirt3
results in increased acetylation of ROS scavengers, but that this
alteration is not sufficient to affect their activity, which may help
to explain the lack of a metabolic phenotype in these two tissue-
specific Sirt3 deficient mouse models.
Discussion
We report here the generation and phenotypic characterization of
the first set of tissue-specific Sirt3 knockout mice (muscle-specific
Sirt3skm2/2 and liver-specific Sirt3hep2/2 mice). Consistent with the
role of Sirt3 as the major mitochondrial deacetylase2, mitochondrial
proteins were robustly hyperacetylated in Sirt3-deficient tissues. In
line with this observation, specific Sirt3 targets, such as mitochon-
drial complex I and the mitochondrial ROS scavenger, Sod2, were
also markedly hyperacetylated in Sirt3-deficient tissues (Fig. 4D), as
previously described in livers from the germline Sirt32/2 mice9,12,13.
However, the activities of these enzymes (Fig. 4H–I) were not chan-
ged in Sirt3-deficient tissues, which indicates that hyperacetylation of
these proteins does not necessarily result in a change in their max-
imal activity. Indeed, while many residues might be acetylated in a
single protein, only the acetylation of a few key residues crucially
determines the enzymatic activity/function of the protein, as demon-
strated with LCAD6. This phenomenon might explain the lack of a
metabolic phenotype in the tissue-specific Sirt3-deficient mice.
Several in vivo and in vitro studies demonstrated a role for Sirt3 in
the suppression of oxidative stress3,8–12,16. However, different groups
have reported normal ROS levels in basal state in liver, brain or
cochlea9,10. In line with these last reports, we observed normal levels
of surrogate markers for ROS in Sirt3-deficient tissues, as well as
similar levels of activity of the mitochondrial ROS scavengers Sod2
and catalase (Fig. 4 H–I). Again, these results might explain the lack
of a clear metabolic phenotype in the conditions we tested.
Despite the higher mitochondrial protein hyperacetylation, the
tissue-specific Sirt32/2 mice described here were metabolically sim-
ilar to control littermates in all the conditions that we tested (chow
and HFD diet, 24 h fasting, exercise or cold). Our results therefore
imply that the previously described phenotypes of germline Sirt32/2
animals under a short fasting or HFD6,9–11,13-15,19 are not due to the
absence of Sirt3 specifically in liver or muscle. Rather, our data indi-
cate that either Sirt3 deficiency in another tissue or the coordinated
defect of Sirt3 in multiple tissues accounts for these effects in the
germline Sirt3 knock-out mice. In this regard, our results do also not
rule out the possibility that latent defects in muscle or liver function
in our models can be fully compensated by another tissue or sirtuin
function. In this sense, further tissue-specific Sirt3 deficient mouse
models exploring the brain, white or brown adipose, or macrophage
function of Sirt3 will be key to fully evaluate the etiology of the
metabolic alterations in the germline Sirt3 knock-out mice. In this
context it is interesting to note that no change in Sirt3 mRNA or
protein expression in non-targeted tissues (Fig. 1B, 1C, 1D and 1E),
nor any change in the mRNA levels of the other mitochondrial
sirtuins (Sirt4 and Sirt5) in the Sirt3-targeted tissues (Fig. 1F and
1G) was present, which suggest that there is no compensation by
other mitochondrial sirtuins. These observations, however, do not
rule out a change in the activity, rather than in mRNA or protein
levels, of these sirtuins as the possible mechanism of compensation.
Of note is also that Sirt3skm2/2 mice, when subjected to a 24 h fast
and, subsequently, to a cold test, do not suffer hypothermia, as prev-
iously reported for the whole-body Sirt3-KO mice6. Since the two
main tissues responsible for temperature homeostasis aremuscle and
brown fat, and Sirt3 is highly expressed in this last tissue, it is tempt-
ing to speculate that Sirt3 in brown fat, but not in skeletal muscle,
plays an important role in temperature homeostasis, most probably
via regulation of mitochondrial uncoupling. Brown fat is also an
important tissue in fat and glucose clearance, and increased brown
fat amounts or activity can significantly improve global metabol-
ism20,21. Thus, one possibility is that the brown fat tissue in
Sirt3hep2/2 and Sirt3skm2/2 mice could compensate for the tissue-spe-
cific ablation of Sirt3 in liver or muscle.
Finally, when comparing studies from different laboratories, it is
important to bear in mind that the genetic background and/or the
exact composition of the diets are key determinants of phenotypic
outcome, which is the result of gene-environment interactions22,23. In
this regard, our mice were on an obesity-prone background (C57BL/
6)23–25 and fed with a standard HFD, with 60% calories coming from
fat, both conditions being different from those used in other
reports14. Furthermore, differences in the developmental onset of
the Sirt3 gene deletions need to be considered, as germline Sirt3-
KO mouse model lacks Sirt3 from the beginning of embryonic
development, while the tissue-specific promoters used in our work
are activated only from a certain developmental stage.
In summary, our work confirms the critical impact of Sirt3 on
global mitochondrial acetylation. It is unclear why these alterations
do not have amajor physiological impact when occurring in a tissue-
specific manner in muscle or liver, as in our study. Further investi-
gations to understand this conundrum are therefore warranted.
Methods
Generation and clinical phenotyping of the Sirt3hep2/2 and Sirt3skm2/2 mice. Sirt3
floxed (Sirt3L2/L2) mice were generated using standard gene targeting procedures26.
These animals were crossed with liver-specific Cre-expressing mice (Alb-Cre)18 to
obtain the Sirt3hep2/2 mouse line; or with the skeletal muscle-specific Cre-expressing
line (HSA-Cre)17 to obtain the Sirt3skm2/2 line. These two mouse lines were
backcrossed onto a pure C57BL/6J background. All animal work in the manuscript
has been performed according to the validated standard operating procedures
(SOPs)23, as defined and validated by the Eumorphia program (see: http://
empress.har.mrc.ac.uk/). Briefly, we subjected our mice to non-invasive monitoring
of body fat and lean mass by EchoMRI; energy expenditure analysis by indirect
calorimetry (CLAMS system); intraperitoneal glucose tolerance test (ipGTT); insulin
tolerance test (ipITT); blood sampling before and after a 24 fast; endurance exercise
on a treadmill; non-invasive blood pressure measurement; and cold test. A summary
of these methods is given in the supplementary materials and methods section.
Animal experiments were approved by the ethic veterinary committee of the canton
of Vaud - Switzerland (Permit IDs 2307 and 2307-1).
Quantitative RT-PCR. qRT-PCR was performed as already described27,28. Briefly,
RNA was extracted from tissues using TRIzol reagent (Invitrogen). Complementary
DNA was generated using QuantiTect Rev (Qiagen). The real-time PCR
measurement of individual cDNAs was performed using SYBR green dye to measure
duplex DNA formation with the LightCycler System (Roche Diagnostics). Primer
sequences are listed in the supplementary materials and methods section.
Complex I, complex IV and citrate synthase activity assays.Complex I, complex IV
and citrate synthase enzymatic activities were measured in homogenates of
gastrocnemius muscle of Sirt3skm1/1 and Sirt3skm2/2 or of livers of Sirt3hep1/1 and
Sirt3hep2/2 mice using the respective enzyme activity assay kits (Mitosciences), as
reported elsewhere29.
Mitochondrial isolation, immunoprecipitation and western blot analysis.
Mitochondria were isolated from tissues following a previously described protocol30.
Isolated mitochondria were lysed in RIPA lysis buffer containing protease inhibitors
and supplemented with 5 mM NAM and 1 mM sodium butyrate.
Immunoprecipitations were performed as described previously28. Protein extracts
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were separated by SDS-PAGE. a-Sirt3 (home-made rabbit polyclonal against the
peptides CDLMQRERGKLDGQDR and STPSGIPDFRSPGSGL), a-Total OxPhos
(MitoSciences, MS604), a-Ndufa9 (Abcam, ab14713), a-AcK (Cell Signaling, 9441),
a-Sod2 (Santa Cruz, sc-133254 for IP, sc-3008 for WB), and a-porin (Calbiochem,
529536) antibodies were used to detect the respective proteins.
Analysis of blood metabolites. For b-hydroxybutyrate (BHBA) analysis, plasma
samples were precipitated with 1 M perchloric acid on ice. After centrifugation the
supernatant was neutralized using 2M KOH, 0.5 M 2-(N-
morpholino)ethanesulfonic acid (MES). BHBA concentrations were measured using
LC-MS/MS in the neutralized supernatant after removal of KClO4. Amino acids and
acylcarnitines were analyzed in plasma according to established LC-MS/MS
methods31,32.
Evaluation of oxidative stress. Sod2 and catalase enzyme activity; HNE; and the
GSH/GSSG ratio weremeasured in liver or gastrocnemiusmuscle homogenates using
a Sod2 and catalase enzyme activity assays (Cayman Chemicals); the OxiSelect HNE-
His Adduct ELISA Kit (Cell Biolabs Inc.); or the Bioxytech GSH/GSSG-412 kit
(OxisResearch TM), respectively, following the manufacturer’s protocols.
ATP measurements. ATP was measured in samples from liver or skeletal muscle
using the ATP determination kit (Molecular Probes, Invitrogen), following previous
reports33 and the manufacturer’s instructions. Briefly, tissues were weighed and lysed
in 600 ml of 6% (v/v) perchloric acid, and centrifuged at 4000xg for 10 minutes at 4uC.
500 ml of the supernatant were neutralized with 200 ml of 2.5 MKOH, and precipitate
was removed by centrifugation at 4000 xg for 5minutes at 4uC. 10 ml of a 1:10 dilution
of the samples in 0.1 M Tris-HCl – 2 mM EDTA buffer (TE) were placed in an
appropriate bioluminescence plate, and luciferase activity was measured after
addition of 100ml of the reaction solution, with a lag time of 1 second and an
integration time of 3 seconds using a Glomax luminometer (Promega).
Preparation and culture of primary mouse hepatocytes and determination of
oxygen consumption rates. Liver cells were prepared by the two-step collagenase
method34 from post-absorptive male mice (25–30 g) after anaesthesia with ketamin/
xylazin (1 mg/100 g body weight). Cell viability (.80%) was checked by trypan blue
exclusion. Primary culture of hepatocytes was seeded at 1.53104 per well on rat-ail
collagen type 1 (BDpharmingen) either on coated XF-96 cell culture plates (Seahorse)
or on 12-well plates in serum-free DMEM (4.5 g/l glucose) medium. Four hours after
seeding, the medium was replaced by a glucose and serum free DMEM medium,
supplemented with lactate 10 mM and pyruvate 1 mM and the cells were infected
with either an adenovirus containing a GFP construct (Adeno-GFP) or an adenovirus
containing a recombinase Cre (Adeno-Cre) construct at a multiplicity of infection
(MOI) of 15. Cellular oxygen consumption rate (OCR) was measured by Seahorse
XF96 forty-eight hours after infection of cells as previously reported35.
Statistical analyses. Statistical analyses were performed with non-parametric
Student’s t-test. Data are expressed as mean 6 SEM and p values smaller than 0.05
were considered as statistically significant. Statistical significance is displayed as
* (p , 0.05) or ** (p , 0.01).
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